Загрузка...
Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications
OBJECTIVE: Hormone receptor-positive breast cancers respond favorably to subcutaneous testosterone combined with an aromatase inhibitor. However, the effect of testosterone combined with an aromatase inhibitor on tumor response to chemotherapy was unknown. This study investigated the effect of testo...
Сохранить в:
| Опубликовано в: : | Menopause |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott-Raven Publishers
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5636057/ https://ncbi.nlm.nih.gov/pubmed/28195993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000000828 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|